Log in

Relevant bibliographies by topics / Bacteriotherapy / Journal articles

To see the other types of publications on this topic, follow the link: Bacteriotherapy.

Journal articles on the topic 'Bacteriotherapy'

Author: Grafiati

Published: 4 June 2021

Last updated: 27 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Bacteriotherapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Amer HASHIM, Zahraa. "BACTERIOTHERAPY." Journal of Research in Pharmacy 27_special_issue_2, no. 27_special_issue_2 (2023): 1–3. http://dx.doi.org/10.29228/jrp.384.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Otto, Grant. "Commensal bacteriotherapy." Nature Reviews Microbiology 19, no. 5 (2021): 283. http://dx.doi.org/10.1038/s41579-021-00546-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kåhrström, Christina Tobin. "Bacteriotherapy triumphs." Nature Reviews Microbiology 10, no. 12 (2012): 804. http://dx.doi.org/10.1038/nrmicro2923.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Famularo, Giuseppe, and Claudio De Simone. "Oral bacteriotherapy." Immunology Today 19, no. 10 (1998): 486–87. http://dx.doi.org/10.1016/s0167-5699(98)01333-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Rode, Anne Abildtrup, Mahtab Chehri, Laura Rindom Krogsgaard, et al. "Randomised clinical trial: a 12‐strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections." Alimentary Pharmacology & Therapeutics 53, no. 9 (2021): 999–1009. http://dx.doi.org/10.1111/apt.16309.

Full text

Abstract:

SummaryBackgroundA defined bacterial mixture could be a safer alternative to faecal microbiota transplantation (FMT).AimsTo compare the efficacy of a 12‐strain mixture termed rectal bacteriotherapy with either FMT or vancomycin for recurrent Clostridioides difficile infection (CDI) in an open‐label 3‐arm randomised controlled trial.MethodsWe screened all individuals positive for C difficile from May 2017 to March 2019. Persons with laboratory‐confirmed recurrent CDI were included. Before FMT and rectal bacteriotherapy, we pre‐treated with vancomycin for 7‐14 days. Rectal bacteriotherapy was ap

APA, Harvard, Vancouver, ISO, and other styles

6

Ciprandi, Giorgio, Valerio Damiani, Vittorio Cordara, and Maria Angela Tosca. "A Brief Review of Local Bacteriotherapy for Preventing Respiratory Infections." Allergies 2, no. 4 (2022): 138–45. http://dx.doi.org/10.3390/allergies2040013.

Full text

Abstract:

Recurrent respiratory infections (RRIs) account for relevant economic and social implications and significantly affect family life. Local Bacteriotherapy (LB) represents an innovative option in preventing RRIs. Local bacteriotherapy consists of administering “good” and safe bacteria (probiotics) by nasal or oral route. In particular, two strains (Streptococcus salivarius 24SMB and Streptococcus oralis 89a) are commonly used. The present article presents and discusses the literature concerning LB. Infections of airways include the upper and lower respiratory tract. A series of clinical trials i

APA, Harvard, Vancouver, ISO, and other styles

7

Alderton, Gemma. "Bacteriotherapy for the skin." Science 371, no. 6535 (2021): 1217.2–1218. http://dx.doi.org/10.1126/science.371.6535.1217-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Peral, Maria C., Miguel A. Huaman Martinez, and Juan C. Valdez. "Bacteriotherapy withLactobacillus plantarumin burns." International Wound Journal 6, no. 1 (2009): 73–81. http://dx.doi.org/10.1111/j.1742-481x.2008.00577.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Soleimanpour, Saman, Seyed Mahdi Hasanian, Amir Avan, Atieh Yaghoubi, and Majid Khazaei. "Bacteriotherapy in gastrointestinal cancer." Life Sciences 254 (August 2020): 117754. http://dx.doi.org/10.1016/j.lfs.2020.117754.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Yaghoubi, Atieh, Majid Khazaei, Seyed Mahdi Hasanian, Amir Avan, William C. Cho, and Saman Soleimanpour. "Bacteriotherapy in Breast Cancer." International Journal of Molecular Sciences 20, no. 23 (2019): 5880. http://dx.doi.org/10.3390/ijms20235880.

Full text

Abstract:

Breast cancer is the second most common cause of cancer-related mortality among women around the world. Conventional treatments in the fight against breast cancer, such as chemotherapy, are being challenged regarding their effectiveness. Thus, strategies for the treatment of breast cancer need to be continuously refined to achieve a better patient outcome. We know that a number of bacteria are pathogenic and some are even associated with tumor development, however, recent studies have demonstrated interesting results suggesting some bacteria may have potential for cancer therapy. Therefore, th

APA, Harvard, Vancouver, ISO, and other styles

11

Borody, Thomas J., Eloise F. Warren, Sharyn M. Leis, Rosa Surace, Ori Ashman, and Steven Siarakas. "Bacteriotherapy Using Fecal Flora." Journal of Clinical Gastroenterology 38, no. 6 (2004): 475–83. http://dx.doi.org/10.1097/01.mcg.0000128988.13808.dc.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Mueller, Anna-Lena, Aranka Brockmueller, Niusha Fahimi, et al. "Bacteria-Mediated Modulatory Strategies for Colorectal Cancer Treatment." Biomedicines 10, no. 4 (2022): 832. http://dx.doi.org/10.3390/biomedicines10040832.

Full text

Abstract:

Colorectal cancer (CRC) is one of the most common tumors worldwide, with a higher rate of distant metastases than other malignancies and with regular occurrence of drug resistance. Therefore, scientists are forced to further develop novel and innovative therapeutic treatment strategies, whereby it has been discovered microorganisms, albeit linked to CRC pathogenesis, are able to act as highly selective CRC treatment agents. Consequently, researchers are increasingly focusing on bacteriotherapy as a novel therapeutic strategy with less or no side effects compared to standard cancer treatment me

APA, Harvard, Vancouver, ISO, and other styles

13

Innocenti, Giuseppe P., Letizia Santinelli, Luca Laghi, et al. "Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial." Metabolites 10, no. 7 (2020): 274. http://dx.doi.org/10.3390/metabo10070274.

Full text

Abstract:

To investigate the effects of oral bacteriotherapy on intestinal phenylalanine and tyrosine metabolism, in this longitudinal, double-arm trial, 15 virally suppressed HIV+ individuals underwent blood and fecal sample collection at baseline and after 6 months of oral bacteriotherapy. A baseline fecal sample was collected from 15 healthy individuals and served as control group for the baseline levels of fecal phenylalanine and tyrosine. CD4 and CD8 immune activation (CD38+) was evaluated by flow cytometry. Amino acid evaluation on fecal samples was conducted by Proton Nuclear Magnetic Resonance.

APA, Harvard, Vancouver, ISO, and other styles

14

&NA;. "Bacteriotherapy for combating bacterial infections?" Inpharma Weekly &NA;, no. 1302 (2001): 3. http://dx.doi.org/10.2165/00128413-200113020-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Connick, Karen. "FECAL BACTERIOTHERAPY OR STOOL TRANSPLANT." Gastroenterology Nursing 32, no. 2 (2009): 135. http://dx.doi.org/10.1097/01.sga.0000349535.03863.16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Seal, D. V., S. P. Borriello, and Mary Piper. "BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE DIARRHOEA." Lancet 334, no. 8662 (1989): 558. http://dx.doi.org/10.1016/s0140-6736(89)90674-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Wilson, KennethH. "BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS." Lancet 334, no. 8671 (1989): 1096. http://dx.doi.org/10.1016/s0140-6736(89)91103-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Huovinen, P. "Bacteriotherapy: the time has come." BMJ 323, no. 7309 (2001): 353–54. http://dx.doi.org/10.1136/bmj.323.7309.353.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Isolauri, Erika, Minna Kaila, Hannu Mykkänen, Wen Hua Ling, and Seppo Salminen. "Oral bacteriotherapy for viral gastroenteritis." Digestive Diseases and Sciences 39, no. 12 (1994): 2595–600. http://dx.doi.org/10.1007/bf02087695.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

TVEDE, M. "Bacteriotherapy for Clostridium difficile diarrhoea." Lancet 335, no. 8681 (1990): 110. http://dx.doi.org/10.1016/0140-6736(90)90574-o.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ferrarelli, Leslie K. "Bugs in the gut dictate food allergy." Science Signaling 12, no. 591 (2019): eaay7815. http://dx.doi.org/10.1126/scisignal.aay7815.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Cavallari, Eugenio Nelson, Giancarlo Ceccarelli, Letizia Santinelli, et al. "Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the “HPVinHIV” Trial." Biomedicines 9, no. 11 (2021): 1738. http://dx.doi.org/10.3390/biomedicines9111738.

Full text

Abstract:

Background. Anal HPV infection, anal dysplasia and, ultimately, anal cancer are particularly common in HIV-infected men who have sex with men. Treatment of anal dysplasia, aiming to prevent evolution to squamous cell carcinoma of the anus, is currently limited to direct ablation and/or application of topical therapy. The aim of the present study is to investigate the effect of oral bacteriotherapy (Vivomixx® in EU, Visbiome® in USA) on anal HPV infection and HPV-related dysplasia of the anal canal in HIV-infected men who have sex with men. Methods. In this randomized, placebo-controlled, quadr

APA, Harvard, Vancouver, ISO, and other styles

23

Nanki, Kosaku, Makoto Naganuma, Shinta Mizuno, Katsuyoshi Matsuoka, and Takanori Kanai. "Bacteriotherapy reintroduces “old friends” in IBD." Inflammation and Regeneration 35, no. 3 (2015): 122–28. http://dx.doi.org/10.2492/inflammregen.35.122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mitchell, Indya, KaSheena Shropshire, and Jennifer Ruel. "Clostridium difficile Infection and Fecal Bacteriotherapy." Gastroenterology Nursing 36, no. 1 (2013): 42–50. http://dx.doi.org/10.1097/sga.0b013e318280f817.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

&NA;. "Clostridium difficile Infection and Fecal Bacteriotherapy." Gastroenterology Nursing 36, no. 1 (2013): 51–52. http://dx.doi.org/10.1097/sga.0b013e318286cfe9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Myers, Frank. "Making the case for fecal bacteriotherapy." Nursing Critical Care 7, no. 4 (2012): 42–46. http://dx.doi.org/10.1097/01.ccn.0000414159.13316.ad.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Rovelli, Roberta, Beatrice Cecchini, Lorenzo Zavagna, et al. "Emerging Multiscale Biofabrication Approaches for Bacteriotherapy." Molecules 29, no. 2 (2024): 533. http://dx.doi.org/10.3390/molecules29020533.

Full text

Abstract:

Bacteriotherapy is emerging as a strategic and effective approach to treat infections by providing putatively harmless bacteria (i.e., probiotics) as antagonists to pathogens. Proper delivery of probiotics or their metabolites (i.e., post-biotics) can facilitate their availing of biomaterial encapsulation via innovative manufacturing technologies. This review paper aims to provide the most recent biomaterial-assisted strategies proposed to treat infections or dysbiosis using bacteriotherapy. We revised the encapsulation processes across multiscale biomaterial approaches, which could be ideal f

APA, Harvard, Vancouver, ISO, and other styles

28

Ciprandi, Giorgio. "Bacteriotherapy for preventing recurrent upper respiratory infections in children: a real-world experience." Otolaryngologia Polska 72, no. 3 (2018): 30–35. http://dx.doi.org/10.5604/01.3001.0012.0482.

Full text

Abstract:

Background Recurrent upper respiratory infections (RURI) constitute a social problem for both their pharmaco-economic impact and the burden for the family. Bacteriotherapy could be an interesting preventive option. Objective The aim of this study was to evaluate the preventive effects of RURI in children. Design The study was designed as spontaneous, and was conducted in real-life seting. Globally, 80 children (40 males, mean age 5.26 (2.52) years) with RURI were enrolled. Children were treated with Streptococcus salivarius 24SMB and Streptococcus oralis 89a: nasal spray 2 puffs per nostril tw

APA, Harvard, Vancouver, ISO, and other styles

29

Neyen, Claudine. "Foundational Article: Mechnikov I, 1909: Intestinal Bacteriotherapy*." Journal of Leukocyte Biology 109, no. 3 (2021): 519–33. http://dx.doi.org/10.1002/jlb.5ri1020-638.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Floch, Martin H. "Fecal Bacteriotherapy, Fecal Transplant, and the Microbiome." Journal of Clinical Gastroenterology 44, no. 8 (2010): 529–30. http://dx.doi.org/10.1097/mcg.0b013e3181e1d6e2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Deshpande, Meghana Ajay, Sudhindra Baliga, Sapna Randad, Nilima Thosar, and Nilesh Rathi. "Probiotic Bacteriotherapy and Its Oral Health Perspective." Journal of Evolution of Medical and Dental Sciences 9, no. 34 (2020): 2479–83. http://dx.doi.org/10.14260/jemds/2020/538.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Borody, Thomas J., Eloise F. Warren, Sharyn Leis, Rosa Surace, and Ori Ashman. "Treatment of Ulcerative Colitis Using Fecal Bacteriotherapy." Journal of Clinical Gastroenterology 37, no. 1 (2003): 42–47. http://dx.doi.org/10.1097/00004836-200307000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Çaglar, E., B. Kargul, and I. Tanboga. "Bacteriotherapy and probiotics’ role on oral health." Oral Diseases 11, no. 3 (2005): 131–37. http://dx.doi.org/10.1111/j.1601-0825.2005.01109.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Inadomi, John M. "ORAL BACTERIOTHERAPY IN PATIENTS WITH CHRONIC POUCHITIS." Evidence-Based Gastroenterology 2, no. 1 (2001): 26–27. http://dx.doi.org/10.1097/00132579-200102000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

SHORNIKOVA, AINO-VIENO, IVAN A. CASAS, HANNU MYKKÄNEN, EEVA SALO, and TIMO VESIKARI. "Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis." Pediatric Infectious Disease Journal 16, no. 12 (1997): 1103–7. http://dx.doi.org/10.1097/00006454-199712000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Bakken, Johan S. "Fecal bacteriotherapy for recurrent Clostridium difficile infection." Anaerobe 15, no. 6 (2009): 285–89. http://dx.doi.org/10.1016/j.anaerobe.2009.09.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Walker, Marsha. "Mammary Dysbiosis." Clinical Lactation 9, no. 3 (2018): 130–36. http://dx.doi.org/10.1891/2158-0782.9.3.130.

Full text

Abstract:

Mastitis can be an unwelcome and debilitating visitor to breastfeeding mothers. The mammary gland has its own microbiome that can be affected by reduced polymorphonuclear neutrophil recruitment during the first 3 months postpartum, as well as the receipt of antibiotics during the last trimester of pregnancy. This can leave the breast vulnerable to pathologic bacterial overgrowth. Mammary dysbiosis is a process whereby the population of potential pathogens increases at the expense of the normal mammary microbiota. Multiresistance to antibiotics plus tricky evasion techniques engaged in by bacte

APA, Harvard, Vancouver, ISO, and other styles

38

Castillo‐González, Raquel, Irene Fernández‐Delgado, and Pasquale Comberiati. "Bacteriotherapy with human skin commensals in atopic dermatitis." Allergy 77, no. 4 (2021): 1331–33. http://dx.doi.org/10.1111/all.15162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ceccarelli, Giancarlo, Massimiliano Marazzato, Luigi Celani, et al. "Oxygen Sparing Effect of Bacteriotherapy in COVID-19." Nutrients 13, no. 8 (2021): 2898. http://dx.doi.org/10.3390/nu13082898.

Full text

Abstract:

Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when administered with the probiotic formulation SLAB51. This study aimed to investigate further bacteriotherapy mechanisms and how early they are activated. Methods: We performed an analysis on the blood oxygenation parameters collected in sixty-nine severe COVID-19 patients requiring non-invasive oxygen therapy and presenting a CT lung involvement ≥50%. Twenty-nine patients received low-molecular-weight heparin, azithromycin and Remdesivir. In a

APA, Harvard, Vancouver, ISO, and other styles

40

Rupnik, Maja. "Toward a True Bacteriotherapy for Clostridium difficile Infection." New England Journal of Medicine 372, no. 16 (2015): 1566–68. http://dx.doi.org/10.1056/nejmcibr1500270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Famularo, G., M. Pieluigi, R. Coccia, P. Mastroiacovo, and C. De Simone. "Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy." Medical Hypotheses 56, no. 4 (2001): 421–30. http://dx.doi.org/10.1054/mehy.2000.1195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Arkkila, Perttu E., Raija Uusitalo-Seppälä, Laura Lehtola, Veikko Moilanen, Matti Ristikankare, and Eero J. Mattila. "29 Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection." Gastroenterology 138, no. 5 (2010): S—5. http://dx.doi.org/10.1016/s0016-5085(10)60023-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bonner, Loren. "Synbiotics, a new alternative in bacteriotherapy, enter market." Pharmacy Today 22, no. 4 (2016): 33. http://dx.doi.org/10.1016/j.ptdy.2016.03.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Twetman, Svante. "Are we ready for caries prevention through bacteriotherapy?" Brazilian Oral Research 26, spe1 (2012): 64–70. http://dx.doi.org/10.1590/s1806-83242012000700010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Taylor-Robinson, D., and I. Rosenstein. "Bacteriotherapy may be useful in treating bacterial vaginosis." BMJ 323, no. 7321 (2001): 1128. http://dx.doi.org/10.1136/bmj.323.7321.1128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hesser, Lauren A., Jeffrey Hubbell, and Cathryn Nagler. "Optimizing bacteriotherapy to prevent or treat food allergy." Journal of Immunology 204, no. 1_Supplement (2020): 158.20. http://dx.doi.org/10.4049/jimmunol.204.supp.158.20.

Full text

Abstract:

Abstract Depletion of protective gut microbes strongly correlates with the increasing prevalence of non-communicable diseases, including food allergies. In previous work we transferred feces from healthy or cow’s milk allergic (CMA) infants to germ free mice and showed that healthy infants harbor intestinal bacteria that are causally protective against food allergy in this model. Monocolonization with a single bacterial species, Anaerostipes caccae, was sufficient to mimic the protective effect of the healthy microbiota. These studies have provided the conceptual basis for the use of bacteriot

APA, Harvard, Vancouver, ISO, and other styles

47

Khardori, N. "Toward a True Bacteriotherapy for Clostridium difficile Infection." Yearbook of Medicine 2015 (2015): 97–98. https://doi.org/10.1016/j.ymed.2015.06.055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Moreno-Gonzalez, Mar, and Naiara Beraza. "The Role of the Microbiome in Liver Cancer." Cancers 13, no. 10 (2021): 2330. http://dx.doi.org/10.3390/cancers13102330.

Full text

Abstract:

Hepatocellular carcinoma (HCC) is the most common malignancy occuring in the context of chronic liver disease and is one of the main causes of cancer-derived death worldwide. The lack of effective treatments, together with the poor prognosis, underlines the urge to develop novel and multidisciplinary therapeutics. An increasing body of evidence shows that HCC associates with changes in intestinal microbiota abundance and composition as well as with impaired barrier function, leading to the release of bacteria and their metabolites to the liver. These factors trigger a cascade of inflammatory r

APA, Harvard, Vancouver, ISO, and other styles

49

Famularo, Giuseppe, Claudio De Simone, Diego Matteuzzi, and Franco Pirovano. "Traditional and High Potency Probiotic Preparations for Oral Bacteriotherapy." BioDrugs 12, no. 6 (1999): 455–70. http://dx.doi.org/10.2165/00063030-199912060-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Matar, Ghassan, and Melhem Bilen. "Culturomics, a potential approach paving the way toward bacteriotherapy." Current Opinion in Microbiology 69 (October 2022): 102194. http://dx.doi.org/10.1016/j.mib.2022.102194.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!